Daily Stock Reporter is issuing a report on four stocks to watch. Minerco Inc (OTCMKTS:MINE), ML Capital Group, Inc. (OTCMKTS:MLCG), Strikeforce Technologies, Inc. (OTCMKTS:SFOR), and Progressive Care, Inc. (OTCMKTS:RXMD) have been added to our watch list today. Continue reading to find out why. – To get daily alerts on top stocks on the OTC, Nasdaq and NYSE subscribe to our newsletter at DailyStockReporter.com.
Minerco Inc (OTCMKTS:MINE) is an emerging company aiming to acquire health conscious consumer brands within the food and beverage sector. As an example, on March 30th Minerco published a press release highlighting their acquiring of the children’s juice brand, Kids 50 – Yo Gabba Gabba! The nutritious children’s beverage contains half of the calories of the average juice box, and serves as an illustration of Minerco’s plan to acquire and grow wholesome food and drink brands. Minerco’s share price has increased 69.15% over the course of the past two trading weeks. On March 24th, Minerco’s stock price experienced a daily low of $0.0201, and then on April 11th, the equity rose to a daily high of $0.034.
Stay Informed and Up To Date On The Hottest Small Cap Nasdaq & OTC Plays. Get Them Here.
ML Capital Group, Inc. (OTCMKTS:MLCG) is a small cap company that has seen its stock price increase 600% over the last four trading weeks. On April 11th, the company’s equity experienced a daily high of $0.0021, which is 600% higher than its March 11th daily low of $0.0003. ML Capital Group has recently undergone a managerial transition, in which Mr. Kevin Bobryk has taken on the responsibilities of being CEO and Chairman of the Board. The company is excited to welcome Mr. Bobryk into a leadership position for he is widely regarded as a, “strategic developer with a successful background orchestrating start-ups as well as elevating organizational performance through skillful restructuring. “
Enjoy picks like this? Get These Alerts and More on top small cap Companies before They Rally, Text the phrase “StockAlerts” to 635-66
Strikeforce Technologies, Inc. (OTCMKTS:SFOR) is in the business of meeting its clients cyber security needs through the use of products that update in real time, act preventively in terms of account creation, and are cost effective. Strikeforce’s suite of products range from computer software, to keyboard security, to mobile device password generators to ensure that all of the company’s customers are digitally secure regardless of the device they are using. In the past three trading weeks, Strikeforce Technologies’ stock price has risen 650%. The increase is a result of the stock reaching a daily high of $0.003 on April 11th, following experiencing a daily low of $0.0004 on March 18th.
Stay Informed and Up To Date On The Hottest Small Cap Stocks; Free To Join Now
Progressive Care, Inc. (OTCMKTS:RXMD) is a health care services company operating in South Florida that is dedicated to treating patients with the care, respect, and privacy that they deserve. They aim to achieve their goal of improving patients’ quality of life by providing them with more access to medication and equipment, raising awareness of diseases, and by providing education to both local communities and long-term care facilities. Over the past four trading weeks, Progressive Care’s stock price has increased 42.67%. On March 14th, the share price experienced a daily low of $0.03, yet on April 11th, the price rose to a high $0.0428 of before the 1 o’clock hour.
Small Cap Stock Alerts: Get Them straight to your Cell Phone. To Receive Our Winning Small Cap Stock Alerts For Free, text “StockAlerts” to 63566.
www.DailyStockReporter.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities. Through a vast network of IR professionals www.DailyStockReporter.com is often in the know of several large investor awareness campaigns being deployed.
Timing is everything when trading Penny Stocks. You can subscribe to the www.DailyStockReporter.com newsletter and start receiving daily alerts. To subscribe by phone and receive messages directly to a mobile phone, text the phrase “StockAlerts” to 63566.
Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
EGM FIRM INC which owns www.DailyStockReporter.com, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release.
EGM FIRM INC, which owns www.DailyStockReporter.com, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice.
EGM FIRM INC which owns www.DailyStockReporter.com, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two.
Contact Email: firstname.lastname@example.org
Eanings Review: Rambus Inc. (NASDAQ:RMBS), Revlon Inc (NYSE:REV)
Revlon Inc(NYSE:REV) +2.5% after-hours after announcing that President and CEO Fabian Garcia is stepping down “to pursue other opportunities,” and Executive Vice Chair Paul Meister will oversee operations on an interim basis.
REV also says it expects Q4 revenues of $785M, below $801M from the year-earlier quarter but ahead of analyst consensus estimate of $743M, and a $60M-$80M net loss for the quarter due to a charge related to the recent tax law changes.
REV expects Q4 adjusted EBITDA of $110M-$115M vs. $115M analyst consensus.
CFO Chris Peterson also denies rumors that the company is considering a material asset transfer that would shield assets from lenders.
Rambus Inc.(NASDAQ:RMBS) shares are down 5.5% aftermarket following Q4 results that beat revenue estimates and met on EPS. In-line Q1 guidance (under ASC 605 accounting change) has revenue from $94M to $100M (consensus: $100.38M) and EPS from $0.17 to $0.23 (consensus: $0.18).
Revenue breakdown: Royalties, $77.9M (+10% Y/Y); Product, $8.5M (-27%); Contract and other revenue, $15.5M (+2%); Licensing billings, $76.6M (+18%).Key metrics: Non-GAAP operating margin, 31%; total operating expenses, $67.5M; cash and equivalents, $172.2M; cash flow from operations, $33.3M.
ADTRAN, Inc. (NASDAQ:ADTN) Hits New Lows After Issuing disappointing Earnings Forecast
ADTRAN, Inc.(NASDAQ:ADTN) slumped to a 52-week low after forecasting below consensus guidance for Q4, revising its revenue estimate downward to $125M from $155M-$165M earlier and seeing EPS of ~$0.01; analysts had expected EPS of ~$0.14 and revenue of $161.2M.
ADTN also projects Q1 to come in at roughly the same as Q4, misses analyst consensus of $167.5M.
CEO Tom Stanton says Q4 results have been hurt by a merger-related review, which ADTN expects to be completed in 60-90 days, and slowdown in the spending at a domestic Tier 1 customer.
MKM Partners analyst Michael Genovese believes the customer is CenturyLink (CTL -2%), which accounted for 24% of ADTN’s total sales in 2016.
The analyst thinks the weakness should prove temporary, adding that ADTN’s performance likely will accelerate into 2019 as the company stands to benefit from 5G spending; MKM trims its ADTN target price to $25 from $27 but keeps its Buy rating.
Big IPO Coming: Celator Pharmaceuticals Inc(NASDAQ:CPXX), Moleculin Biotech’s (MBRX)
Today at 10am Eastern, Moleculin Biotech ticker symbol MBRX will debut on the Nasdaq stock exchange and is being considered as one of the most highly anticipated IPO’s of 2016 by the street. The excitement and anticipation is arising from many experts saying that Moleculin Biotech’s (MBRX) drug annamycin is far superior to Celator Pharmaceuticals Inc(NASDAQ:CPXX) drug daunorubicin.
CPXX which has been bought out by Jazz Pharmaceuticals plc – Ordinary Shares(NASDAQ:JAZZ) for $1.5 Billion Dollars last week, share price ran from $1.6 to $31 in 2 months. Moleculin Biotech’s share structure is a 1.5m public float Priced at $6.